Bio-techne share price today

(TECH)

Bio-techne share price is $74.73 & ₹6,471.09 as on 15 Jan 2025, 2.30 'hrs' IST

$74.73

▲

-1.69

(-2.21%)

Market is closed - opens 8 PM, 15 Jan 2025

View live Bio-techne share price in Dollar and Rupees. Guide to invest in Bio-techne stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bio-techne, along with analyst recommendations, forecasts, and comprehensive financials.

Bio-techne share price movements

Today's Low: $74.15
Today's High: $78.38
$74.73
0.78%
Downside
Day's Volatility :5.4%
Upside
4.66%
52 Weeks Low: $61.16
52 Weeks High: $85.57
$74.73
18.16%
Downside
52 Weeks Volatility :28.53%
Upside
12.67%

Bio-techne Returns

Period	Bio-techne Corp.	Sector (Health Care)	Index (Russel 2000)
3 Months	4.08%	-8.4%	0.0%
6 Months	-4.55%	-5.2%	0.0%
1 Year	4.62%	-0.4%	0.0%
3 Years	-21.13%	4.4%	-18.2%

Bio-techne Key Statistics

in dollars & INR

Previous Close	$76.42
Open	$76.48
Today's High	$78.38
Today's Low	$74.15
Market Capitalization	$12.1B
Today's Volume	$1.3M
52 Week High	$85.57
52 Week Low	$61.16
Revenue TTM	$1.2B
EBITDA	$308.5M
Earnings Per Share (EPS)	$0.99
PE Ratio	77.19
Dividend Yield	0.44%
Profit Margin	12.86%
Quarterly Earnings Growth YOY	-0.32%
Return On Equity TTM	7.29%

How to invest in Bio-techne from India?

It is very easy for Indian residents to invest directly in Bio-techne from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bio-techne stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bio-techne or TECH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bio-techne or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bio-techne shares which would translate to 0.012 fractional shares of Bio-techne as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bio-techne, in just a few clicks!

Returns in Bio-techne for Indian investors in Rupees

Investment Value

₹1,00,000

Bio-techne investment value today

Current value as on today

₹1,08,945

Returns

₹8,945

(+8.95%)

Returns from Bio-techne Stock

₹4,620 (+4.62%)

Dollar Returns

₹4,325 (+4.33%)

Indian investors sentiment towards Bio-techne

-27%

Period: Oct 16, 2024 to Jan 14, 2025. Change in 30 Days versus previous period

Search volume for Bio-techne on INDmoney from India has reduced in the last 30 days as on Jan 15, 2025. -27% less investors are searching Bio-techne in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Bio-techne

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	1371	-1.32	0.02%

Global Institutional Holdings in Bio-techne

Vanguard Group Inc
11.53%
BlackRock Inc
8.71%
T. Rowe Price Associates, Inc.
5.93%
State Street Corp
4.03%
Morgan Stanley - Brokerage Accounts
2.93%
BAMCO Inc
2.80%

Analyst Recommendation on Bio-techne

Buy

84%Buy

15%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Bio-techne(by analysts ranked 0 to 5 stars)

Based on 19 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Bio-techne

What analysts predicted

Upside of 14.09%

Target:

$85.26

Current:

$74.73

Insights on Bio-techne

Price Movement
In the last 1 month, TECH stock has moved down by -1.3%
Decreasing Revenue
Revenue is down for the last 2 quarters, 306.09M → 289.45M (in $), with an average decrease of 5.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 49.05M → 33.6M (in $), with an average decrease of 17.2% per quarter
TECH vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.4% return, outperforming this stock by 20.9%
TECH vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 62.0% return, outperforming this stock by 85.4%
Price to Sales
ForTECH every $1 of sales, investors are willing to pay $10.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.6 for every $1 of sales.

Bio-techne Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$714.0M	↑ 11.04%
Net Income	$96.1M	↓ 23.36%
Net Profit Margin	13.46%	↓ 6.03%

	FY20	Y/Y Change
Revenue	$738.7M	↑ 3.46%
Net Income	$229.3M	↑ 138.67%
Net Profit Margin	31.04%	↑ 17.58%

	FY21	Y/Y Change
Revenue	$931.0M	↑ 26.04%
Net Income	$140.4M	↓ 38.76%
Net Profit Margin	15.08%	↓ 15.96%

	FY22	Y/Y Change
Revenue	$1.1B	↑ 18.75%
Net Income	$272.1M	↑ 93.75%
Net Profit Margin	24.61%	↑ 9.53%

	FY23	Y/Y Change
Revenue	$1.1B	↑ 2.81%
Net Income	$285.3M	↑ 4.86%
Net Profit Margin	25.1%	↑ 0.49%

	FY24	Y/Y Change
Revenue	$1.2B	↑ 1.97%
Net Income	$168.1M	↓ 41.07%
Net Profit Margin	14.5%	↓ 10.6%

	Q2 FY23	Q/Q Change
Revenue	$301.3M	↑ 2.44%
Net Income	$75.5M	↑ 7.5%
Net Profit Margin	25.05%	↑ 1.18%

	Q3 FY23	Q/Q Change
Revenue	$276.9M	↓ 8.09%
Net Income	$51.0M	↓ 32.45%
Net Profit Margin	18.41%	↓ 6.64%

	Q4 FY23	Q/Q Change
Revenue	$272.6M	↓ 1.57%
Net Income	$27.5M	↓ 46.14%
Net Profit Margin	10.08%	↓ 8.33%

	Q1 FY24	Q/Q Change
Revenue	$303.4M	↑ 11.31%
Net Income	$49.1M	↑ 78.62%
Net Profit Margin	16.17%	↑ 6.09%

	Q2 FY24	Q/Q Change
Revenue	$306.1M	↑ 0.88%
Net Income	$40.6M	↓ 17.27%
Net Profit Margin	13.26%	↓ 2.91%

	Q3 FY24	Q/Q Change
Revenue	$289.5M	↓ 5.44%
Net Income	$33.6M	↓ 17.22%
Net Profit Margin	11.61%	↓ 1.65%

	FY19	Y/Y Change
Profit	$473.5M	↑ 9.57%

	FY20	Y/Y Change
Profit	$483.2M	↑ 2.05%

	FY21	Y/Y Change
Profit	$632.9M	↑ 30.97%

	FY22	Y/Y Change
Profit	$756.5M	↑ 19.54%

	FY23	Y/Y Change
Profit	$769.8M	↑ 1.76%

	FY24	Y/Y Change
Profit	$769.7M	↓ 0.01%

	Q2 FY23	Q/Q Change
Profit	$204.7M	↑ 1.25%

	Q3 FY23	Q/Q Change
Profit	$185.2M	↓ 9.53%

	Q4 FY23	Q/Q Change
Profit	$176.6M	↓ 4.65%

	Q1 FY24	Q/Q Change
Profit	$205.2M	↑ 16.23%

	Q2 FY24	Q/Q Change
Profit	$204.9M	↓ 0.18%

	Q3 FY24	Q/Q Change
Profit	$183.0M	↓ 10.67%

	FY19	Y/Y Change
Operating Cash Flow	$181.6M	↑ 6.6%
Investing Cash Flow	$-336.8M	↑ 770.01%
Financing Cash Flow	$134.4M	↓ 235.48%

	FY20	Y/Y Change
Operating Cash Flow	$205.2M	↑ 12.99%
Investing Cash Flow	$27.1M	↓ 108.04%
Financing Cash Flow	$-183.8M	↓ 236.77%

	FY21	Y/Y Change
Operating Cash Flow	$352.2M	↑ 71.61%
Investing Cash Flow	$-243.5M	↓ 998.75%
Financing Cash Flow	$-62.6M	↓ 65.97%

	FY22	Y/Y Change
Operating Cash Flow	$325.3M	↓ 7.64%
Investing Cash Flow	$-96.9M	↓ 60.23%
Financing Cash Flow	$-242.9M	↑ 288.25%

	FY23	Y/Y Change
Operating Cash Flow	$254.4M	↓ 21.79%
Investing Cash Flow	$-265.6M	↑ 174.29%
Financing Cash Flow	$22.6M	↓ 109.31%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$83.4M	↑ 65.02%
Investing Cash Flow	$-4.8M	↓ 98.03%
Financing Cash Flow	$-24.2M	↓ 116.06%

Bio-techne Technicals Summary

Sell

Neutral

Buy

Bio-techne is currently in a neutral trading position according to technical analysis indicators.

Bio-techne Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bio-techne Corp.	-1.88%	-4.55%	4.62%	-21.13%	35.5%
Biontech Se	-1.57%	30.02%	12.92%	-33.56%	238.85%
Regeneron Pharmaceuticals, Inc.	-4.69%	-36.36%	-26.29%	13.03%	79.01%
Vertex Pharmaceuticals Incorporated	-12.06%	-15.71%	-5.9%	78.15%	74.56%
Alnylam Pharmaceuticals, Inc.	-1.43%	0.2%	28.28%	72.79%	102.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bio-techne Corp.	77.19	77.19	2.81	1.89	0.07	0.06	0.0	13.46
Biontech Se	160.8	NA	0.04	-3.2	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	17.24	17.24	1.06	44.97	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.08	0.48	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bio-techne Corp.	Buy	$12.1B	35.5%	77.19	12.86%
Biontech Se	Buy	$27.3B	238.85%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$77.5B	79.01%	17.24	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$106.5B	74.56%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$33.3B	102.42%	NA	-15.86%

Bio-techne Dividend announcements

Bio-techne Dividends December, 2024
In the quarter ending December,2024. Bio-techne has declared dividend of $0.08
Read More

About Bio-techne

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company has strategic partnership with ALZpath, Inc. to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Organization	Bio-techne
Employees	3100
CEO	Mr. Kim Kelderman
Industry	Health Technology

Management People of Bio-techne

Name	Title
Mr. Kim Kelderman	CEO, President & Director
Mr. James T. Hippel CPA	Executive VP of Finance & CFO
Mr. Shane Bohnen	Senior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer
Mr. William A. Geist	President of Protein Sciences Segment
Dr. Matthew F. McManus M.D., MBA, Ph.D.	President of Diagnostics & Genomics
Dr. Gary J. Latham Ph.D.	VP & CTO
Mr. David Clair C.F.A.	Senior Director of Investor Relations & Corporate Development
Mr. Gerry Andros	Vice President of Sales and Marketing
Mr. Martin Wirtz	Senior Vice President of Strategy & Corporate Development
Ms. Cheryl Bethune	Senior VP & Chief Human Resources Officer

Important FAQs about investing in Bio-techne from India :

What is Bio-techne share price today?

Bio-techne share price today stands at $74.73, Open: $76.48 ; Previous Close: $76.42 ; High: $78.38 ; Low: $74.15 ; 52 Week High: $85.57 ; 52 Week Low: $61.16. The stock opens at $76.48, after a previous close of $76.42. The stock reached a daily high of $78.38 and a low of $74.15, with a 52-week high of $85.57 and a 52-week low of $61.16.

Can Indians buy Bio-techne shares?

Yes, Indians can invest in the Bio-techne (TECH) from India.

With INDmoney, you can buy Bio-techne at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bio-techne at zero transaction cost.

How can I buy Bio-techne shares from India?

It is very easy to buy Bio-techne from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bio-techne be purchased?

Yes, you can buy fractional shares of Bio-techne with INDmoney app.

What are the documents required to start investing in Bio-techne stocks?

To start investing in Bio-techne, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.